Company Monitoring Page for Avastin

latest headlines for company on cafepharma

3 Big Biotech Stocks With Big-Time Catalysts
Motley Fool
Sun, 04/9/17 - 12:36 pm
Tags:
Regeneron, Praluent, Amgen, biosimilars, Amjevita, Humira, ABP-215, Avastin, ABP-980, Herceptin, Celgene, ozanimod
The 19 Best-Selling Prescription Drugs of All-Time
Motley Fool
Mon, 03/13/17 - 11:29 am
Tags:
Lipitor, Humira, Seretide, Remicade, Plavix, Enbrel, Rituxan, Herceptin, Avastin, Nexium, Zyprexa
The Demise of the BPCIA Patent Dance?
FDA Law Blog
Fri, 03/3/17 - 09:40 am
Tags:
BPCIA, patents, Genentech, Amgen, Sandoz, Avastin
Amgen and the BPCIA Patent Dance – Redux
FDA Law Blog
Mon, 02/20/17 - 10:07 am
Tags:
Amgen, patents, BPCIA, FDA, Sandoz, Neupogen, generics, Genentech, Avastin
Amgen, Allergan Seek EU OK for Avastin Biosimilar
Investopedia
Mon, 12/5/16 - 09:59 am
Tags:
Amgen, Allergan, Avastin, biosimilars, Europe, ABP 215, non-squamous lung cancer
Amgen, Allergan step up to challenge Roche's Avastin with FDA biosim filing
Fierce Pharma
Wed, 11/16/16 - 09:57 am
Tags:
Amgen, Allergan, Roche, Avastin, biosimilars, FDA, ABP 215
Roche adjusts Avastin franchise defense plans as PhII successor fails a key study
Endpoints
Fri, 10/21/16 - 10:01 am
Tags:
Roche, Avastin, Vanucizumab
Roche rules out quality problems with Avastin in India
BioPharma Dive
Sat, 04/16/16 - 04:02 pm
Tags:
Roche, Avastin, India, off-label
India reclears Roche's Avastin for off-label eye sales
Fierce Pharma Marketing
Mon, 03/14/16 - 05:53 pm
Tags:
India, Roche, Avastin, off-label
Roche's pharma chief sees no 'short term' pricing pressure on its cancer blockbusters
Fierce Pharma
Mon, 02/1/16 - 01:49 pm
Tags:
Roche, drug pricing, Rituxan, Avastin, Herceptin
Off-label use of Avastin in India hospitalizes 15, sales halted in two states
BioPharma Dive
Wed, 01/20/16 - 09:35 pm
Tags:
Avastin, India, off-label, Roche, wet age-related macular degeneration
Biosimilars Are Coming After Big Pharma's Bottom Line
Fortune
Tue, 01/12/16 - 02:37 pm
Tags:
Big Pharma, biosimilars, Roche, AbbVie, MabThera, Herceptin, Avastin, Humira, Janssen, Remicade
Roche CEO Slams `Stupid' U.K. Decision to Drop Some Cancer Drugs
Bloomberg
Tue, 09/8/15 - 08:22 am
Tags:
Roche, Pharma CEOs, UK, cancer, Avastin, Severin Schwan
Eylea erodes Lucentis, Avastin market share
Medical Marketing and Media
Tue, 08/4/15 - 06:10 pm
Tags:
Eylea, Lucentis, Avastin, Regeneron, Roche/Genentech
Biosimilars will cut top 10 vulnerable biologics almost in half by 2020: Morningstar
Fierce Pharma Marketing
Wed, 07/22/15 - 09:36 pm
Tags:
biosimilars, AbbVie, Roche, Amgen, Rituxan, Herceptin, Avastin, Neupogen, Neulasta, Epogen, Humira, Perjeta, Gazyva
Did Novartis try to sabotage Avastin ophthalmic trials?
BioPharma Dive
Mon, 04/6/15 - 10:54 am
Tags:
Novartis, Avastin, Roche, Lucentis
BMJ: Novartis tried to 'scupper' trials to protect Lucentis from cheap Avastin
Fierce Pharma
Thu, 04/2/15 - 11:52 am
Tags:
Novartis, clinical trials, Roche, Avastin, Lucentis
Genentech denies knowledge of distribution-related problems
BioPharma Dive
Thu, 03/5/15 - 11:12 am
Tags:
Genentech, distribution, Avastin, Herceptin, Rituxan
Genentech Distribution Shift for Cancer Meds Delays Patient Care: Survey
WSJ Pharmalot
Mon, 03/2/15 - 12:29 pm
Tags:
Genentech, Avastin, Rituxan, Herceptin, distribution
UK doctors lobby for off-label Avastin use
Medical Marketing and Media
Tue, 02/24/15 - 06:59 pm
Tags:
UK, Avastin, off-label, Lucentis, wet age-related macular degeneration, Roche, Novartis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.